What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Diabetes mellitus
Elisabetta Bugianesi mainly focuses on Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Fatty liver and Endocrinology.
Her study in Insulin resistance, Cirrhosis, Liver disease, Metabolic syndrome and Liver biopsy is done as part of Internal medicine.
Her Nonalcoholic fatty liver disease research incorporates elements of Steatosis, Liver transplantation, Hepatology, Fibrosis and Type 2 diabetes.
Her work carried out in the field of Gastroenterology brings together such families of science as Odds ratio, Hepatitis B, Surgery and Risk factor.
Her research investigates the connection between Fatty liver and topics such as Liver function that intersect with problems in Family history and Homeostatic model assessment.
Elisabetta Bugianesi focuses mostly in the field of Endocrinology, narrowing it down to matters related to Biopsy and, in some cases, Single-nucleotide polymorphism.
Her most cited work include:
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (2124 citations)
- Nonalcoholic fatty liver disease a feature of the metabolic syndrome (1996 citations)
- Association of nonalcoholic fatty liver disease with insulin resistance (1273 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Fatty liver, Endocrinology and Nonalcoholic fatty liver disease.
Her study on Insulin resistance, Cirrhosis, Non alcoholic and Fibrosis is often connected to In patient as part of broader study in Internal medicine.
Her Insulin resistance study integrates concerns from other disciplines, such as Phlebotomy, Chronic hepatitis and Metabolic syndrome.
Elisabetta Bugianesi has included themes like Diabetes mellitus, Hepatocellular carcinoma and Liver biopsy in her Gastroenterology study.
The study incorporates disciplines such as Steatosis, Type 2 diabetes and Cohort in addition to Fatty liver.
Her Nonalcoholic fatty liver disease research is multidisciplinary, relying on both Liver disease and Obesity.
She most often published in these fields:
- Internal medicine (78.87%)
- Gastroenterology (46.95%)
- Fatty liver (38.26%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (78.87%)
- Gastroenterology (46.95%)
- Fatty liver (38.26%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Gastroenterology, Fatty liver, Disease and Non alcoholic are her primary areas of study.
In general Internal medicine, her work in Fibrosis, Nonalcoholic fatty liver disease, Chronic liver disease and Cirrhosis is often linked to In patient linking many areas of study.
Her Nonalcoholic fatty liver disease research incorporates themes from Liver disease, Gut flora and Obesity.
Her study in Gastroenterology is interdisciplinary in nature, drawing from both Hepatocellular carcinoma, Biopsy and Hazard ratio.
Her Fatty liver research includes elements of Steatosis, Endocrinology, Transient elastography and Cohort.
Her study in Insulin resistance and Insulin falls under the purview of Endocrinology.
Between 2018 and 2021, her most popular works were:
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (309 citations)
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates (201 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her primary scientific interests are in Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Steatohepatitis and Fatty liver.
Her research combines Endocrinology and Internal medicine.
Her research integrates issues of Diabetes mellitus, Gut flora and Obesity in her study of Nonalcoholic fatty liver disease.
Her Gastroenterology research includes themes of Crohn's disease and Hepatocellular carcinoma.
Her Steatohepatitis study combines topics from a wide range of disciplines, such as Cirrhosis, Socioeconomic status, Public health and Cancer research.
The various areas that Elisabetta Bugianesi examines in her Fatty liver study include Steatosis, Protein kinase B, Oncostatin M, National Health and Nutrition Examination Survey and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
